PP at RM0.36, why not buy from market cheaper? Either operator push it lower for the subscriber or the company's is grossly undervalued.
On behalf of the Board, TA Securities wishes to announce that the Board had on to-date (“Price-fixing Date”) fixed the issue price for the placement of 25,000,000 Placement Shares at RM0.36 per Placement Share (“Issue Price”).
China Secures 100 Million Doses of BioNTech Vaccine Bloomberg News December 15, 2020, 10:16 PM EST Updated on December 16, 2020, 1:56 AM EST BioNTech to supply vaccines to Fosun as part of marketing pact Imported vaccines needed despite massive domestic production The Pfizer-BioNTech Covid-19 vaccine. The Pfizer-BioNTech Covid-19 vaccine. Photographer: Bing Guan/Bloomberg A Chinese drugmaker has secured 100 million doses of the coronavirus vaccine co-developed by Pfizer Inc. and BioNTech SE, as the country seeks overseas shots in addition to home-made ones to ensure immunization for the world’s most populous nation.
Shanghai Fosun Pharmaceutical Group Co., which in March made an agreement with BioNTech to develop and market the mRNA shot in China, will make an advance payment of 250 million euros ($300 million) for an initial 50 million doses. The German vaccine maker will supply no fewer than 100 million doses for China by the end of 2021, Fosun said in a statement filed with the Hong Kong Stock Exchange Wednesday
The Issue Price represents a premium of approximately 8.30% to the 5-day VWAP of Yong Tai Shares up to and including 15 December 2020 of RM0.3324, being the last market day immediately preceding the Price-fixing Date.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
luckyTurtle
6 posts
Posted by luckyTurtle > 2020-12-16 15:46 | Report Abuse
big selling pressure at 0.340 - 0.345